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a  b  s  t  r  a  c  t
Four  peptide  sequences  corresponding  to  the  E1  protein  of  GBV-C:  NCCAPEDIGFCLEGGCLV  (P7),  APEDIGF-
CLEGGCLVALG  (P8),  FCLEGGCLVALGCTICTD  (P10)  and  QAGLAVRPGKSAAQLVGE  (P18)  were  studied  as
they were  capable  of interfering  with  the  HIV-1  fusion  peptide  (HIV-1  FP).  In this  work,  the  surface  prop-
erties  of  the E1  peptide  sequences  are  investigated  and  their  physicochemical  characterization  is done
by  studying  their interaction  with  model  membranes;  moreover,  their  mixtures  with  HIV-1  FP were also
studied in order  to observe  whether  they  are  capable  to  modify  the  HIV-1  FP  interaction  with  model
membranes  as  liposomes  or monolayers.  Physicochemical  properties  of peptides  (pI  and  net charge)
were  predicted  showing  similarities  between  P7  and  P8,  and  P10 and  HIV-1  FP,  whereas  P18  appears  to
be  very  different  from  the rest.  Circular  dichroism  experiments  were  carried  out  showing  an  increase  of
the  percentage  of  -helix  of  P7  and  P8 when  mixed  with  HIV-1  FP  corroborating  a  conformational  change
that  could  be  the  cause  of  their  inhibition  ability.  Penetration  experiments  show  that  all  the  peptides  can
spontaneously  insert  into  phospholipid  membranes.  Analysis  of  compression  isotherms  indicates  that
the  peptides  interact  with  phospholipids  and  the  E1  peptides  modify  the compression  isotherms  of  HIV-
1 FP,  but  there  is one  of the peptides  that  excelled  as the best candidate  for inhibiting  the  activity  of  HIV-1
FP, P7,  and  therefore,  that  could  be  potentially  used  in  future  anti-HIV-1  research.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
The independently discovered human viruses GB virus C (GBV-
C) (Simons et al., 1995) and hepatitis G virus (HGV) (Linnen et al.,
1996) are two isolates of the same single-stranded RNA virus. GBV-
C shows characteristics of a flavivirus-like genome, closely related
to the hepatitis C virus (HCV). The virus infects lymphocytes, but
not hepatocytes and there is no conclusive evidence of a causal link
between GBV-C and either acute or chronic liver disease. Recently,
GBV-C has been investigated in the context of human immunodefi-
ciency virus (HIV) infection and there are some reports finding that
co-infection prolonged survival of patients and served as a poten-
tially effective treatment (Tillmann and Manns, 2001; Xiang et al.,
2001, 2004). Based on a co-infection model, GBV-C may  influence
HIV disease via inhibition of HIV by inducing chemokines, down-
regulating the HIV co-receptor(s), influencing cytokine profiles, or
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having other – as yet undefined – effects on the host lymphocytes
(Xiang et al., 2001, 2004). However, the mechanism responsible
for the beneficial effect that the GBV-C virus has on the course of
disease caused by HIV has not yet been identified (Bhattarai and
Stapleton).
We are currently examining the capacity of GBV-C synthetic
peptides to interact and to induce fusion in model membranes
(Sánchez-Martín et al., 2009, 2010) The capacity, observed in vitro,
to inhibit the leakage of vesicular contents caused by the HIV-1
fusion peptide (HIV-1 FP) is the property that allows us to select
the sequences of the envelop protein E1 of GBV-C/HGV in order to
study their interaction with model membranes and with HIV-1 FP.
In this work, four peptides corresponding to the E1 protein of
GBV-C are selected as possible inhibitors of the activity of HIV-1 FP
(Sánchez-Martín et al., 2011a).
The aim of this work is to study the effect of the E1 peptides
on the activity of the peptide sequence that represents the 23-
mer  N-terminal domain of the surface protein gp41 of HIV which
corresponds to HIV-1 FP.
Surface properties are among the most important features of
biomaterials. Surface functional groups and their arrangement in
0378-5173/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
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the nanoscale topology of the material surface have dramatic effects
on amount, orientation, and conformation of adsorbed proteins.
For these reasons, adsorption and conformational change of pro-
teins on biomaterial surfaces are widely considered to be one of
the most important mechanisms controlling interactions between
biomaterials and the surrounding biological system.
Small variations in primary structure strongly affect the local
predisposition toward secondary structure in smaller peptides. -
Helix (Parthasarathy et al., 1995), -sheet (Ramirez-Alvarado et al.,
1997), and a variety of turns (Perczel and Hollosi, 1996) have been
reported for short peptides. These are consistently found to depend
strongly on the primary structure. For example, in model -helical
peptides, favorable intramolecular electrostatic interactions arising
from charged side chains are frequently used to stabilize -helicity
(Andrews and Tabor, 1999). In contrast, polypeptides lacking such
specific interactions follow the entropic bias toward a “random
coil” conformation, in which the average dihedral angles follow
local torsional energetic, independent of surrounding residues
(Brant and Flory, 1965).
As a continuation of a previous works carried out in our group
(Sánchez-Martín et al., 2011a),  the surface properties of the E1
peptide sequences are investigated and their physicochemical
characterization is done by studying their interaction with model
membranes; lipopeptide interactions with lipid monolayers




In addition, conformational analysis by circular dichroism was
carried out in presence of liposomes as model membranes. More-
over, we are interested in study the conformational changes when
HIV-1 FP is in presence of E1 peptides in order to know if it is one





glycerol) (DPPG) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPG) were purchased from Avanti Polar
Lipids. Their purity was higher than 99% and they were used
without further purification.
Chloroform and methanol were purchased from Merck. Water
was double distilled and deionised (MilliQ system, Millipore)
(18.2 M cm,  pH 5.8). Buffer in all experiments was  HEPES (from
Sigma–Aldrich) 5 mM  and NaCl (from Merck) 20 mM,  pH 7.4.
2.2. Methods
2.2.1. Peptides synthesis
The peptides corresponding to E1 protein of GBV-C:
NCCAPEDIGFCLEGGCLV (P7), APEDIGFCLEGGCLVALG (P8), FCLEG-
GCLVALGCTICTD (P10) and QAGLAVRPGKSAAQLVGE (P18), and
the HIV-1 FP, AVGIGALFLGFLGAAGSTMGAAS, were obtained by
solid-phase methodologies and purified by preparative high
performance liquid chromatography, as previously described
(Sánchez-Martín et al., 2011a).
2.2.2. Preparation of multilamellar vesicles
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPG)
and peptides were dissolved in a chloroform:methanol (2:1, (v/v))
mixture. Different mixtures of POPG and E1 peptides with or
without HIV-1 FP were done and the solutions were evaporated
to dryness in vacuum with a rotary evaporator. The dried lipid
film was subjected to a high vacuum overnight to remove trace
amounts of solvent. Then, the lipid films were hydrated with
double distilled and deionised water to obtain multilamellar
vesicles (MLVs).
2.2.3. Bioinformatic analysis tools for peptide characterization
Physicochemical properties of peptides (pI and net charge)
were predicted using the Isoelectric Plot calculation program
at http://www.bioinformatics.org/JaMBW//3/1/6/index.html.
Hydrophobicity profiles were obtained
by means of a calculation program at
http://www.vivo.colostate.edu/molkit/hydropathy/index.html,
using the Hopps and Woods scale with a window size of 6.
2.2.4. Circular dichroism
CD spectra were recorded on a Jasco J-810 spectropolarimeter
(Japan Spectroscopic Company, Tokyo). All measurements were
done in water. Cells 1 cm in diameter were used and the spectra
were measured between 170 and 250 nm using a spectral band-
width of 1 nm and a scan speed of 10 nm/min.
All measurements were performed at 25 ◦C and the
data were expressed in terms of mean residue elliptici-
ties [] (deg cm2 dmol−1). Three scans were accumulated to
improve the signal to noise ratio. Before reading the pep-
tide spectra, a spectrum of the blank solution was  subtracted
and the data converted to mean residue ellipticity units.
(Greenfield, 2006) Moreover, Contin by the Dichroweb server
at http://dichroweb.cryst.bbk.ac.uk/html/home.shtml program
was used to treat experimental CD results (Lobley et al., 2002;
Whitmore and Wallace, 2004).
The percentage of -helix conformation in the peptides was
estimated using the formalism of Chen et al. (1974) This approach
assumes that the maximum theoretical ellipticity for a given pep-
tide or protein at 222 nm may  be derived from the number of amino
acid residues n, and the ellipticity at 222 nm of a helix of infinite
length described by Eq. (1).
%˛ − helix = []222[
−39500 (1 − 2.75/n)
] (1)
2.2.5. Adsorption at the air–water interface
Adsorption studies at the air–water interface were carried out
using a NIMA Langmuir Film Balance equipped with a Wilhelmy
platinum plate (Nima Technology, Coventry) and a Teflon trough
that was  rinsed with ethanol and distilled water before use. All
experiments were performed at room temperature.
The surface activity of peptides was  first studied to determine
the equilibrium spreading pressure. Using a cylindrical PTFE trough
(19.6 cm2, 27.2 cm3), increasing volumes of a 0.28 mM peptide solu-
tion were injected below HEPES subphase (pH 7.4) through a lateral
hole and the adsorption of the peptide at the air/water interface was
therefore monitored by following the increase in surface pressure
as a function of time under continuous stirring of the subphase.
2.2.6. Insertion of peptides into monolayers
The kinetics of insertion of the peptides into monolayers of
DMPG and DPPG were measured using the same trough as for the
surface activity. For these experiments, a lipid stock solution was
prepared and added drop wise on the subphase until the desired
lipid pressure was achieved. After 10–20 min  the equilibrium of the
lipid monolayer was reached. Then, a 0.28 mM peptide solution was
injected into the subphase through the side hole of the trough. The
subphase was  magnetic stirred during the measurements and sur-
face pressure changes were monitored as function of time until it
remained constant.
Author's personal copy
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2.3. Compression isotherms
Compression isotherms were carried out on a Nima (UK)
Langmuir Teflon trough (surface area 595 cm2, volume 280 cm3).
By depositing appropriate volumes of chloroform stock solu-
tions of phospholipids (0.28 mM)  and of peptides (0.28 mM),  the
lipid–peptide spreading solutions were obtained. Monolayers were
formed by applying small drops of the spreading solutions on the
HEPES subphase (pH 7.4) with a micro syringe (Hamilton Co., Reno,
NV). After 15 min, monolayers of the desired composition were con-
tinuously compressed with an area reduction rate of 15 cm2 min−1.
The films were compressed to their collapse pressure when possi-
ble. Each run was repeated three times and the reproducibility was
±1 Å2 molecule−1.
2.3.1. Epifluorescence experiments
Surface pressure–area measurements and microscopic observa-
tions of phospholipid monolayers were performed using a specially
designed Langmuir–Blodgett (LB) trough (200 cm2, Nima Technol-
ogy, Inc., Coventry, UK) equipped with a continuous Teflon-ribbon
barrier able to sustain maximal surface pressures with no leak-
age, and thermostated at the desired temperature. The trough
was set inside a custom-made closed chamber to ensure isolation
from external light. Films were transferred onto a Menzel-Gläser
24 mm × 60 mm cover slips at a rate of substrate movement of
5 mm/min  while the film was compressed to obtain the complete
–A isotherm as described previously (Wang et al., 2007). The
entire transferred film typically occupied a length of ∼20 mm on
the substrate. –A isotherms were simultaneously recorded during
the transfer.
To form monolayers, the lipids DPPC and DPPG, and their mix-
tures with peptides (5% with respect to phospholipid, mol/mol)
were prepared in chloroform/methanol (3:1, (v/v)), and 1 mol  %
of NBD-PC was included. Monolayers were spread by depositing
very small aliquots of the chloroform/methanol solutions on a
double distilled water subphase. After spreading of a monolayer,
the organic solvent was allowed to evaporate for 5 min, and the
monolayer was compressed at 25 cm2 min−1 to a surface pressure
of 3 mN/m and let to stabilize for 10 min. Then, the compression
isotherm was registered.
The transferred monolayers were observed in a Leica DM4000B
microscope (Leica Microsystems, Wetzlar, Germany) equipped
with the appropriate fluorescence filters to allow for the observa-
tion of NBD-PC fluorescence (maximum fluorescence excitation at
480 nm and emission at 527 nm). Images were obtained at differ-
ent positions from the transferred films and subsequently assigned
to the surface pressures obtained during film transfer (Wang et al.,
2007).
3. Results and discussion
3.1. Bioinformatic analysis tools for peptide characterization
Physical properties such as the isoelectric point (pI)  or the net
charge at pH 7.4 (pH of the study) of the peptides were predicted
in order to know whether the behavior of the different sequences
is related to these properties. Results are shown in Table 1.
P7 and P8 present similar values of both properties, whereas the
pI and the charge of P10 are the most close to those of HIV-1 FP. In
the contrary, P18 differs much from the rest.
3.2. Circular dichroism
In order to gain insights into the differences between peptides
and their interaction with HIV-1 FP, a conformational study was
carried out. Circular dichroism experiments and the corresponding
Table 1
Prediction of the Isoelectric point and the net charge at pH 7.4 for HIV-1 FP and E1
synthetic peptides.
Isoelectric point Net charge at pH 7.4
HIV-1 FP 6 −0.1
P7 2.88 −3.5
P8  2.88 −3.2
P10 3.18 −1.5
P18 11.38 +2
quantitative analysis of the experimental data using a deconvo-
lution computer program were done. In general, short synthetic
peptides do not have a preferential conformation in solution, but
can sometimes adopt moderately stabilized secondary structures
(Pérez et al., 1998). CD experiments were carried out in presence of
POPG vesicles as it was  found that HIV-1 bound to negative phos-
pholipids stronger than to lipids devoid of a net charge (Wu et al.,
2002). Firstly, CD spectra of the peptides separately were recorded.
Afterwards, E1 peptides were incubated with HIV-1 FP and added
to the liposomes solution.
In this work, we  used CD to analyze if the ability of the E1
peptides to bind HIV-1 FP induces a conformational change in its
secondary structure. In this sense, CD spectra of the HIV-1 FP in
presence of POPG liposomes showed a negative band with a peak
around 215 nm which could be attributed to a -structure contribu-
tion probably due to peptide aggregation (Fig. 1). In this medium,
the peptide spectrum also showed a negative band near 195 nm
that is typical of random coil conformation.
On the other hand, in P7, P8 and P18 spectra, the characteristic
positive band around 195 nm appeared showing the spectra like
those of an -helix structure, and they also show a negative band
with a peak between 215 and 220 nm which could be attributed to a
-structure contribution. CD spectra of P10 also showed a negative
band near 195 nm,  typical of random coil conformation.
The experimental CD spectrum of the mixture of E1 peptides
and HIV-1 FP in aqueous solution is different from the theoretical
spectrum obtained by summing experimental spectra of equiva-
lent amounts of the peptides alone (dotted spectra in Fig. 1); thus,
the results suggest that the E1 peptides interact with HIV-1 FP.
The mixture demonstrated that the addition of E1 peptides to the
HIV-1 FP decreased the mean residue ellipticity at 215 nm, thus
decreasing the percentage of -structure. Therefore, E1 peptides
seem to inhibit the aggregation propensity when mixed with HIV-1
FP, showing an interaction between the peptides.
Table 2 shows the estimation, from the CD spectra, of the con-
tent of -helical conformation of the peptides according to molar
ellipticity at 222 nm (calculated from Eq. (3)). These results slightly
differ from the obtained in a previous work (Sánchez-Martín et al.,
2011b) where we  performed a CD study of these peptides to
know the capacity of them to adopt secondary structure in an
hydrophobic environment. Now we use POPG vesicles instead of
Table 2
Estimation, from the CD spectra, of the content of -helical conformation of the
HIV-1 FP and E1 peptides according to molar ellipticity at 222 nm.




P7  + HIV-1 FP 9.3
P8 6.1
P8  + HIV-1 FP 6.4
P10 5.2
P10 + HIV-1 FP 7.2
P18 11.6
P18 + HIV-1 FP 6.4
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Fig. 1. CD spectra of E1 synthetic peptides and HIV-1 FP in presence of POPG liposomes in a Hepes buffer solution, recorded at 298 K.
trifluoroethanol (TFE), an halogenated alcohol that it is known
induces -helical conformation in peptides. So the -helical con-
tent is lower in this case. On the other hand this is a normal behavior
observed in other E1 peptides that were studied (Fernández-Vidal
et al., 2008).
First, results show that P18 has a high percentage of -helix
compared to the rest and the percentage obtained for P10 is equal
to that obtained for HIV-1 FP; these results are coherent with those
obtained in Table 1, showing that P10 and P18 behave different
from P7 and P8, and that P10 has some similarities with HIV-1 FP.
This similarity obtained here corroborates the results obtained in
a previous work where we observed that P10 could be an internal
fusion peptide of GBV-C, as HIV-1 FP, and it was discarded as a
possible inhibitor of HIV-1 FP. P18 is the peptide that presents the
highest change in the conformation when mixed with the HIV-1 FP,
showing a clear interaction between both peptides.
3.3. Adsorption at the air–water interface
Fig. 2 shows the adsorption isotherm profile for the E1 synthetic
peptides. A small gradual adsorption of peptide was observed at low
peptide concentration. The higher the peptide concentration in the
subphase the faster the incorporation process and the higher the
surface pressure attained. The shape of the surface activity curves
















Fig. 2. Surface activity curve of E1 synthetic peptides.
approximates a rectangular hyperbola and it was fitted to Eq. (2)
via non-linear least squares regression analysis.
 = Cmax
K + C (2)
where C is the concentration, max is the maximum pressure
achieved and K is a characteristic constant equal to the peptide
concentration that yields (1/2)max. Fitting the data, the values
obtained are shown in Table 3. These K values were chosen to
further penetration studies, as K corresponds to the suitable con-
centration of the peptide that should be used in the bulk subphase
for experiments of penetration kinetics, lower than the equilibrium
spreading pressure of the peptide (Rafalski et al., 1990).
By applying the Gibbs adsorption equation in its simpler form
(Eq. (3)) it is possible to calculate the peptide surface excess con-
centration ( )
 = 
RT  ln c
(3)
where R is the gas constant (8.31 J K−1 mol), T is the temperature
(298 K),   is the maximum pressure increase achieved for each
peptide concentration and C is the peptide concentration.
The surface excess concentration of the E1 synthetic peptides
at saturation ( max) deduced from the slope of the –ln C curve
(Eq. (3)) allows us to calculate the surface molecular area by means





Clearly, the four peptides decrease the surface tension of the
air–water interface. However, their hydrophobic profiles based on
their primary sequence are very different and this fact induces dif-
ferent behaviors. The main difference is the greater decrease in
tension induced by P10, this suggests that P10 develops stronger
hydrophobic interactions than the others when engaged in an air-
water interface most likely because they adopt different structural
states. This fact is corroborated with the hydrophobicity plot of P10
obtained using Hopp–Woods scale that was designed for predicting
potentially antigenic regions of polypeptides. In this type of plots,
values greater than 0 are hydrophilic and thus likely to be exposed
on the surface of a folded protein. For P10 all the values in the plot
are negative, showing a high hydrophobicity profile, as HIV-1 FP
Author's personal copy
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Table  3
Analysis of the adsorption isotherms of the E1 synthetic peptides. max is the maximum pressure achieved and K is a characteristic constant equal to the peptide concentration
that  yields (1/2)max  max is the surface excess concentration at saturation and A is the molecular area.
max (mN  m−1) K (M) r2  max (×1022 res m−2) A (Å2 res−1)
P7 17.22 0.55 0.953 1.85 5.40
P8  12.14 0.21 0.993 1.20 8.34
P10  28.49 0.62 0.966 2.79 3.59
P18 9.20 0.46 0.947 0.83 12.05
also presenting negative values in the plot. P7 and P8 have nega-
tive values from the residues 8 to 15 and 4 to 15, respectively, and
P18 shows negative values for the residues 3 to 5 and 14 to 15, being
the less hydrophobic peptide and corroborating the low max value
obtained at the adsorption isotherm.
3.4. E1 synthetic peptides insertion into phospholipid monolayers
The ability of the E1 peptides to insert into phospholipid
monolayers spread at the air–water interface was  monitored by
measuring variations in surface tension using different initial
pressures, and by injecting a given peptide concentration in the
subphase. The selected concentration corresponds to the K values
calculated in Section 3.3. Various penetration experiments were
carried out using two different phospholipids, DMPC and DMPG,
where the nature of the headgroups (zwitterionic and negatively
charged) is different. For both lipids, the general trend observed
is that the greater i, the lower the degree of incorporation of the
peptide into the monolayer because of the closer packing of the
lipids at higher initial pressures (Fig. 3).
The monolayer exclusion pressure e (that is, the surface
pressure above which the peptide does not penetrate into
the monolayer) was obtained by extrapolating the plot to
 = 0 mN m−1 (Bougis et al., 1981). It can be seen that the peptide
interacts with the two lipids tested; the nature of the headgroups
has influence on penetration for all peptides except for P18. DMPG
form anionic monolayers while monolayers of DMPC are zwitte-
rionic. The insertion of the peptides in the anionic monolayers is
lower than in the zwitterionic, probably due to the negative charge
of the peptides; however, P18, that is positively charged, interacts
in the same way with both phospholipids. The e is similar for all
the peptides except for P10 that has a e for DMPC higher than
the others peptides, indicating a better uptake by this zwitterionic
phospholipid.
3.5. Spreading at the air–water interface: compression isotherms
The compression isotherms for the E1 peptides and their mix-
tures with HIV-1 FP when mixed with DMPC and DMPG were
obtained. We  could observe how the shape of the isotherms of
HIV-1 FP and phospholipids changes drastically when HIV-1 FP is
mixed with any of the other E1 peptides (figure not shown). The
isotherms were analyzed by examining the variation of the mean
molecular area (that of the contributions of both the peptide and the
lipid) as a function of the peptide/lipid ratio at a given and constant
surface pressure. These variations are reported in Fig. 4 and corre-
spond to a pressure of 10 mN/m,  although for 5, 20 and 30 mN/m
the same trends are observed for all the peptides. Analysis of the
plots reveals several similar situations in both lipid–peptide com-
binations. First, they show a nonlinear behavior for all the peptides
and their mixtures, indicating that all the peptides are miscible and
interact with the phospholipids assayed (Gaines, 1966). The mixed
monolayers present positive deviations of ideality, at any peptide
molar fraction assayed, except when HIV-1 FP is mixed with P7,
suggesting that the peptides interact with phospholipids through
repulsive interactions (Galvez and Cabrerizo, 1991). Although all
the E1 peptides decrease the deviations caused by HIV-1 FP, P7
is the only one that make these deviations become negative and,
at lower XHIV-1 FP+P7, they show an ideal behavior. The contraction
observed in the case of P7 indicates that peptide–lipid interactions
are attractive and may  reflect the formation of peptide–lipid com-
plexes through hydrophobic interactions (Deshayes et al., 2004).






































































Fig. 3. Surface pressure increase () caused by E1 synthetic peptides in monolayers of different phospholipids in front of the lipid initial pressure (i). Grey squares
correspond to DMPG and black circles to DMPC. (a) P7, (b) P8, (c) P10 and (d) P18.
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Fig. 4. Plots of Amolec for the mixtures of E1 peptides and HIV-1 FP as a function
of  the peptides molar fractions for mixed monolayers of: (a) DMPC and (b) DMPG.
Dotted lines indicate ideality.
The deviations from ideality of the mixed monolayers of P18 with
DMPG are smaller than for the other peptides, this behavior is
related with the positive charge of P18 and, therefore, the elec-
trostatic attraction towards DMPG. These results are coherent with
those observed in previous assays where P7 stood out as one with
the highest capacity to inhibit the fusion peptide activity (Sánchez-
Martín et al., 2011a).
3.6. Compression isotherms: epifluorescence experiments
To further characterize the lipid physical state of the monolay-
ers in presence and in absence of the peptides, mixed monolayers
of DPPC and DPPG with P7 and HIV-1 FP were compressed and
transferred to a solid substrate in order to observe them by epi-
fluorescence microscopy. Fig. 5 shows the surface pressure–area
per molecule (–A) isotherms of DPPC (Fig. 5a) and DPPG (Fig. 5b)
mixed with P7, HIV-1 FP and the mixture P7: HIV-1 FP (2:1). The
isotherms showed that the presence of P7 or HIV-1 FP in the
subphase caused an expansion of the DPPC film, suggesting that
the peptide is occupying some space in the interface, or, at least it
is interacting with the phospholipid monolayer sufficiently to per-
turb the usual lipid packing. The mixture of both peptides showed
an smaller expansion than when peptides are alone, demonstrat-
ing an interaction between both peptides. In the case of DPPG, the
presence of the peptides caused a compression of the DPPG film,
but again we  could observe that when mixing P7 and HIV-1 FP the
effect of HIV-1 FP is drastically reduced.
Microscopic observations of DPPC monolayers containing
1 mol% NBD-PC transferred to glass cover slips showed the typical
domain coexistence along the phase transition beginning around
9 mN/m and observed as a plateau in the –A isotherm (Fig. 6). Liq-
uid expanded and liquid condensed (LE–LC) coexistence regions are
observed as dark LC domains excluding the fluorescent probe and
bright green areas of LE phase similar to those previously observed
in situ at the Langmuir through (Nag et al., 1991, 1996; Perez-Gil
et al., 1992).
When 5% of P7 peptide is added to the monolayer composition, a
matrix of a branched structure could be observed in the monolayer
at low pressures, probably due to the presence of the peptide in the
interphase. At higher pressures where the phase transition starts,
this net is less evident indicating a partial remixing of the peptide
in the lipid bulk. Indeed, the peptide produces a change in the lipid
phase transition, reducing the size and increasing the number of
condensed domains, with a less effect in the total condensed phase
at any surface pressure. The presence of peptide could induce an
increase in the nucleation points where the condensed domains
grow. This effect can also explain the presence of small condensed
domains at pressures below the one where the phase transition
starts in monolayers made with lipid alone.
The addition of HIV-1 FP to DPPC monolayers had a similar effect
producing a decrease in the domain size. In contrast to P7, HIV-1 FP
does not seem to increase the number of condensed domains and
slightly increases the surface pressure where the domains start no
nucleate. At higher pressures the domains grow with shapes sim-
ilar to the observed in the lipid monolayers but with less average
condensed areas than the observed in the DPPC monolayer. The
combination of both peptides produces an intermediate situation
where effects of the presence of P7 and HIV-1 FP can be observed.
P7 produce an initial peptide network an also reduce the size of the
condensed domains but the effect of HIV-1 FP can also be observed
as reduction of the number and of domains and total condensed
area. At higher pressures (see Fig. 6 at ∼18 mN/m), structures sim-
ilar to the observed in presence of P7 or HIV-1 FP alone can be
observed in the same epifluorescence frame, suggesting a separate
effect of each peptide in DPPC monolayers.
The effect of the peptides in the structure of monolayers of
DPPG was  also analyzed by epifluorescence microscopy (Fig. 7).
The monolayers of DPPG showed a phase transition from liquid
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Fig. 5. Surface pressure–mean area per molecule (–A) compression isotherms of (a) DPPC and (b) DPPG monolayers mixed with P7, HIV-1 FP and their mixture 2:1.
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Fig. 6. Epifluorescence images from DPPC monolayers with or without 5% of peptides P7, HIV-1 FP or the combination 2:1 (mol/mol) of P7:HIV-1 FP. Images were taken at
positions matching the indicated surface pressure from the LB films transferred during continuous compression. Images size: 216.56 m × 164.96 m.
expanded to liquid condensed phase at lower surface pressures
than observed in DPPC monolayer, showing more rounded and
numerous domains. The images obtained in the presence of any
peptide separately show dark percolated regions that could be
explained as and increment of the condensed phase of the lipid or
even as regions where the peptides segregate. The detection of the
presence of the peptide in these regions require of further experi-
ments using fluorescent peptides. The presence of these dark areas
Fig. 7. Epifluorescence images from DPPG monolayers with or without 5% of P7, HIV-1 FP or a 2:1 (mol/mol) mixture of P7: HIV-1 FP. Images were taking at positions
matching the indicated surface pressure from the LB films transferred during continuous compression. Images size: 216.56 m × 164.96 m.
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coexists with vast regions where the effect of the peptide over the
lipid phase transition become more evident appearing as a reduc-
tion of the size of the condensed domains, this effect is more patent
at higher pressures (∼20 mN/m)  where the monolayer of pure DPPG
is almost totally condensed. However, if DPPG was prepared in the
presence of a 2:1 molar ratio mixture of both peptides, P7 and HIV-
1 FP respectively, the monolayer seems to be less affected than
when each peptide was added separately. The films show domains
with regular size and shapes, similar to those present in the pure
lipid monolayer, and less dark regions. The combined effect of the
peptides in DPPG monolayers could be explained in terms of a
peptide/peptide interaction.
4. Conclusions
The present investigations try to offer some light on the interac-
tion of four sequences corresponding to E1 protein of GBV-C with
the HIV-1 FP in order to get further into the study carried out in a
past work. Previously, P10 was discarded as a possible inhibitor of
the HIV-1 FP activity and was suggested as a possible fusion peptide
of GBV-C (Sánchez-Martín et al., 2011a); these results are now cor-
roborated in this study. We  have found that pI and the charge of P10
are the most close to those of HIV-1 FP as well as the estimation of
the content of -helical conformation according to molar ellipticity
at 222 nm is equal for both peptides. Moreover, P10 shows stronger
hydrophobic interactions when engaged in an air–water interface
than the others, corroborated by Hopp and Woods hydrophobicity
profile that is also very similar to HIV-1 FP profile.
P18 was found not to inhibit the interaction with bilayers or the
membrane fusion caused by HIV-1 FP. The present results show
that P18 is the least hydrophobic of all and it is the only one that,
in presence of HIV-1 FP, reduces its percentage of -helix instead
of increasing it as the others. Compression isotherms show its high
miscibility with the negatively charged phospholipid and how it
is capable of reducing the expansion of the mean molecular area
caused by HIV-1 FP; thus, we have another evidence of its ability to
inhibit the activity of HIV-1 FP in the same way that it was capable
of inhibiting the leakage of vesicular contents caused by HIV-1 FP.
P7 and P8 behave very similar. They were capable of inhibit-
ing the leakage of vesicular contents, the membrane fusion and the
interaction with bilayers of HIV-1 FP. These results reflect again
the similarities between both peptides as the pI and the net charge,
the surface activity curves or the increase of the percentage of -
helix when mixed with HIV-1 FP corroborating a conformational
change that could be the cause of the inhibition effect. Moreover,
the contraction of the mean molecular area observed in the case of
HIV-1 FP in presence of P7 indicates that peptide–lipid interactions
are attractive and may  reflect the formation of peptide–lipid com-
plexes through hydrophobic interactions. The interaction between
P7 and HIV-1 FP was also observed by isothermal titration calorime-
try were the binding of P7 to HIV-1 FP was found to be endothermic
(Sánchez-Martín et al., 2011a). On the contrary, P8 does not seem to
change the deviations in the mean molecular area caused by HIV-1
FP nor its interaction with HIV-1 FP in solution was observed by
isothermal titration calorimetry.
In conclusion, after several studies to evaluate the possibility of
using synthetic peptides corresponding to the envelop protein E1 of
GBV-C in future anti-HIV research, there is one of the peptides stud-
ied that excels in all the experiments, P7, that corresponds to the
region E1 (19–36); therefore, this peptide could be potentially used
in future anti-HIV-1 therapies. P8 and P18 are capable of inhibiting
some actions that HIV-1 FP has on membrane models, therefore,
we could not discard them and we need to investigate deeply these
peptides to understand the reason for this ability and why  they do
not act in same way in all the experiments assayed.
Being in mind that the action of drugs is at physiological con-
ditions, it is necessary also to investigate the temperature effect
on the observed behavior of peptides, mainly for P7 peptide. It
is known the conformation of peptides, surface properties and
peptide–lipid interaction parameters change with temperature. In
case of E1 (145–162) sequence, a new specie appears at a spe-
cific molar fraction depending on the temperature (Sánchez-Martín
et al., 2009), so its effect cannot be discarded.
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